当前位置: 首页 > 医学版 > 期刊论文 > 临床医学 > 中华急诊医学杂志 > 2010年 > 第11期 > 第4期 > 正文
编号:11976660
他汀类降脂药能降低缺血性脑卒中患者再发卒中的风险(2)
http://www.100md.com 2010年4月1日 张韩英
第1页

    参见附件(1151KB,2页)。

     参考文献

    [1] 他汀类药物预防缺血性脑卒中/短暂性脑缺血发作专家组.他汀类药物预防缺血性脑卒中/TIA专家建议.中国卒中杂志,2007,2:340-343.

    [2] Larry B Goldstein,Robert Adams,Mark J Alberts,et al. Primary prevention of ischemic stroke: a guideline from the American heart association/American stroke association stroke council. Stroke,2006,37:1583-1633.

    [3] Wolf PA,Kannel WB,Verter J. Current status of risk factors for stroke. Neurol Clin,1983,1:317-343.

    [4] Zhang X,Patel A,Horibe H,et al. Asia pacific cohort studies collaboration cholesterol,coronary artery disease,and stroke in the asia pacific region. Int J Epidemiol,2003,32:563-572.

    [5] Bots ML,Elwood PC,Nikitin Y,et al. Total and HDL cholesterol and risk of stroke. EUROSIROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health,2002,56:19-i24.

    [6] Cholesterol Treatment Trialist’ (CTT) Collaborators. Effects and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet,2005,366:1267-1278.

    [7] O’Regan C,Wu P,Aroa P,et al. Statin therapy in stroke prevention: a meta-analysis involving 121 000 patients. The American journal of medicine,2008,121:24-33.

    [8] Amarenco P,Goldstein LB,Szarek Michael,et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the stroke prevention by aggressive reduction in cholesterol levels (sparcl) trial. Stroke,2007,38:3198-3204.

您现在查看是摘要介绍页,详见PDF附件(1151KB,2页)